These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 22260409)

  • 1. New insights into uric acid effects on the progression and prognosis of chronic kidney disease.
    Filiopoulos V; Hadjiyannakos D; Vlassopoulos D
    Ren Fail; 2012; 34(4):510-20. PubMed ID: 22260409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease.
    Kang DH; Nakagawa T
    Semin Nephrol; 2005 Jan; 25(1):43-9. PubMed ID: 15660334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperuricemia, Hypertension, and Chronic Kidney Disease: an Emerging Association.
    Mallat SG; Al Kattar S; Tanios BY; Jurjus A
    Curr Hypertens Rep; 2016 Oct; 18(10):74. PubMed ID: 27696189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD.
    Srivastava A; Kaze AD; McMullan CJ; Isakova T; Waikar SS
    Am J Kidney Dis; 2018 Mar; 71(3):362-370. PubMed ID: 29132945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between hyperuricemia and chronic kidney disease.
    Ohno I
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1039-44. PubMed ID: 22132954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for uric acid in the progression of renal disease.
    Kang DH; Nakagawa T; Feng L; Watanabe S; Han L; Mazzali M; Truong L; Harris R; Johnson RJ
    J Am Soc Nephrol; 2002 Dec; 13(12):2888-97. PubMed ID: 12444207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study.
    Oh TR; Choi HS; Kim CS; Bae EH; Ma SK; Sung SA; Kim YS; Oh KH; Ahn C; Kim SW
    Sci Rep; 2019 Apr; 9(1):6681. PubMed ID: 31040373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to target uric acid to retard CKD progression.
    Kumagai T; Ota T; Tamura Y; Chang WX; Shibata S; Uchida S
    Clin Exp Nephrol; 2017 Apr; 21(2):182-192. PubMed ID: 27339448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.
    Rodenbach KE; Schneider MF; Furth SL; Moxey-Mims MM; Mitsnefes MM; Weaver DJ; Warady BA; Schwartz GJ
    Am J Kidney Dis; 2015 Dec; 66(6):984-92. PubMed ID: 26209544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges of conducting a trial of uric-acid-lowering therapy in CKD.
    Badve SV; Brown F; Hawley CM; Johnson DW; Kanellis J; Rangan GK; Perkovic V
    Nat Rev Nephrol; 2011 May; 7(5):295-300. PubMed ID: 21321568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid: a novel mediator and marker of risk in chronic kidney disease?
    Feig DI
    Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):526-30. PubMed ID: 19654543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function.
    Zoppini G; Targher G; Chonchol M; Ortalda V; Abaterusso C; Pichiri I; Negri C; Bonora E
    Diabetes Care; 2012 Jan; 35(1):99-104. PubMed ID: 22028277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The uric acid cardio-nephropathy].
    Viazzi F; Bonino B; Cappadona F; Pontremoli R
    G Ital Nefrol; 2017 Mar; 34(Suppl 69):41-48. PubMed ID: 28682028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uric acid and long-term outcomes in CKD.
    Madero M; Sarnak MJ; Wang X; Greene T; Beck GJ; Kusek JW; Collins AJ; Levey AS; Menon V
    Am J Kidney Dis; 2009 May; 53(5):796-803. PubMed ID: 19303683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperuricemia and the progression of chronic kidney disease: is uric acid a marker or an independent risk factor?
    Nashar K; Fried LF
    Adv Chronic Kidney Dis; 2012 Nov; 19(6):386-91. PubMed ID: 23089273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease.
    Sampson AL; Singer RF; Walters GD
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009460. PubMed ID: 29084343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperuricemia and chronic kidney disease: an enigma yet to be solved.
    Dousdampanis P; Trigka K; Musso CG; Fourtounas C
    Ren Fail; 2014 Oct; 36(9):1351-9. PubMed ID: 25112538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum uric acid levels are associated to renal arteriolopathy and predict poor outcome in IgA nephropathy.
    Russo E; Drovandi S; Salvidio G; Verzola D; Esposito P; Garibotto G; Viazzi F
    Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2343-2350. PubMed ID: 32912790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of febuxostat in patients with allopurinol-refractory hyperuricemic chronic kidney disease
.
    Kwak CH; Sohn M; Han N; Cho YS; Kim YS; Oh JM
    Int J Clin Pharmacol Ther; 2018 Jul; 56(7):321-327. PubMed ID: 29750634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
    Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
    Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.